7-105547276-C-T
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_021930.6(RINT1):c.782C>T(p.Pro261Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000485 in 1,614,022 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P261R) has been classified as Uncertain significance.
Frequency
Consequence
NM_021930.6 missense
Scores
Clinical Significance
Conservation
Publications
- infantile liver failure syndrome 3Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- infantile liver failure syndrome 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RINT1 | NM_021930.6 | c.782C>T | p.Pro261Leu | missense_variant | Exon 6 of 15 | ENST00000257700.7 | NP_068749.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RINT1 | ENST00000257700.7 | c.782C>T | p.Pro261Leu | missense_variant | Exon 6 of 15 | 1 | NM_021930.6 | ENSP00000257700.2 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152152Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000298 AC: 75AN: 251486 AF XY: 0.000338 show subpopulations
GnomAD4 exome AF: 0.000510 AC: 745AN: 1461870Hom.: 1 Cov.: 32 AF XY: 0.000495 AC XY: 360AN XY: 727230 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000250 AC: 38AN: 152152Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74318 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:3Benign:1
- -
- -
The RINT1 p.Pro183Leu variant was not identified in the literature nor was it identified in Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs199535472) and ClinVar (classified as uncertain significance by Invitae). The variant was identified in control databases in 85 of 282892 total chromosomes at a frequency of 0.0003005 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: European (Finnish) in 23 of 25124 chromosomes (freq: 0.000916), Other in 4 of 7228 chromosomes (freq: 0.000553), European (non-Finnish) in 57 of 129192 chromosomes (freq: 0.000441) and African in 1 of 24970 chromosomes (freq: 0.00004), but was not observed in the Latino, Ashkenazi Jewish, East Asian or South Asian populations. The p.Pro183 residue is not conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
- -
not specified Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at